Excellent result and well above expectations. You don't see many companies achieving this sort of growth in this market. The breath and quality of their product range together with their expanding distribution via Priceline sets up a very encouraging growth platform for the coming year. I'm looking forward to see what can be achieved with this company. BIO is definitely in my top stock picks for 2023.
Ann: FY22 Revenue Guidance, page-2
Add BIO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
68.0¢ |
Change
0.005(0.74%) |
Mkt cap ! $149.0M | |||
| Open | High | Low | Value | Volume |
| 68.5¢ | 70.5¢ | 67.0¢ | $138.5K | 202.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 5587 | 67.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 68.0¢ | 129 | 1 |
View Market Depth
| Last trade - 16.10pm 09/10/2024 (20 minute delay) ? |
| BIO (ASX) Chart |